I agree that this site is using cookies. You can find further informations here.
X
Li, Jielang
13  results:
Search for persons X
?
1

A SwinTransformer-Based Segmentation Framework With Self-Su..:

Miao, Dong ; Li, Jielang ; Dou, Meng...
IEEE Journal of Biomedical and Health Informatics.  28 (2024)  1 - p. 403-414 , 2024
Link: https://doi.org/10.1109/..
 
?
2

Effectiveness of PD-1 inhibitor-based first-line therapy in..:

Duan, Yichun ; Li, Jielang ; Zhou, Shuang.
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
3

Favorable response to PD-1 inhibitor plus chemotherapy as f..:

Li, Jielang ; Ren, Min ; Bi, Feng..
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
4

Capecitabine/cisplatin combined with concurrent intensity-m..:

Li, Jielang ; Huang, Chen ; Wang, Xin..
Clinical and Translational Oncology.  26 (2023)  3 - p. 739-746 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Casp8 acts through A20 to inhibit PD‐L1 expression: The mec..:

Zou, Jiahuan ; Xia, Hongwei ; Zhang, Chenliang...
Cancer Science.  112 (2021)  7 - p. 2664-2678 , 2021
Link: https://doi.org/10.1111/..
 
?
6

Efficacy of lenvatinib plus pembrolizumab in hepatocellular..:

Li, JieLang ; Chen, Ting ; Bi, Feng.
Tumori Journal.  107 (2021)  6 - p. NP114-NP119 , 2021
Link: https://doi.org/10.1177/..
 
?
7

TLR3 activation efficiency by high or low molecular mass po..:

Zhou, Yu ; Guo, Ming ; Wang, Xu...
Innate Immunity.  19 (2012)  2 - p. 184-192 , 2012
Link: https://doi.org/10.1177/..
 
?
8

Casp8 acts through A20 to inhibit PD‐L1 expression: The mec..:

Zou, Jiahuan ; Xia, Hongwei ; Zhang, Chenliang...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253292/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

TLR3 activation efficiency by high or low molecular mass po..:

Zhou, Yu ; Guo, Ming ; Wang, Xu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942089.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
10

Favorable response to PD-1 inhibitor plus chemotherapy as f..:

Jielang Li ; Min Ren ; Feng Bi..
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1228653/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
11

Table_1_Favorable response to PD-1 inhibitor plus chemother..:

Jielang Li ; Min Ren ; Feng Bi..
doi:10.3389/fimmu.2023.1228653.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
12

Development of iron supported carbon foam catalyst for Fisc..:

Huang, Jielang ; Zhu, Zongbo ; Zhang, Dandan...
Reaction Kinetics, Mechanisms and Catalysis.  135 (2022)  5 - p. 2457-2473 , 2022
Link: https://doi.org/10.1007/..
 
?
13

Physicochemical, conformational properties and ACE-inhibito..:

Guo, Shanguang ; Ai, Minmin ; Liu, Jielang...
LWT.  101 (2019)  - p. 469-475 , 2019
Link: https://doi.org/10.1016/..
 
1-13